16.26
+0.16
+(0.99%)
As of 10:41:59 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
86,053.00
8,800.00
-59,508.00
-112,369.00
-102,002.96
Investing Cash Flow
-7,232.00
-4,981.00
-13,911.00
-13,511.00
-12,724.68
Financing Cash Flow
-66,271.00
-38,989.00
108,852.00
121,048.00
143,896.66
End Cash Position
86,707.00
51,352.00
86,522.00
51,089.00
55,921.15
Interest Paid Supplemental Data
--
18,051.00
13,880.00
11,159.00
10,267.63
Capital Expenditure
-7,232.00
-4,981.00
-13,911.00
-13,511.00
-12,726.68
Issuance of Capital Stock
--
--
64,645.00
121,144.00
131,195.29
Issuance of Debt
--
135,000.00
151,750.00
--
27,500.00
Repayment of Debt
-188,585.00
-158,601.00
-100,036.00
-34.00
-13,982.07
Free Cash Flow
78,821.00
3,819.00
-73,419.00
-125,880.00
-114,729.64
12/31/2020 - 10/17/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CORT Corcept Therapeutics Incorporated
68.62
-1.83%
SMMT Summit Therapeutics Inc.
22.08
-1.25%
TGTX TG Therapeutics, Inc.
33.42
+0.17%
CPRX Catalyst Pharmaceuticals, Inc.
23.04
-0.65%
MESO Mesoblast Limited
20.22
+3.56%
VRNA Verona Pharma plc
57.73
+0.86%
EXEL Exelixis, Inc.
33.45
+1.58%
BBIO BridgeBio Pharma, Inc.
36.18
+0.58%
ARDX Ardelyx, Inc.
5.30
-1.21%
JANX Janux Therapeutics, Inc.
44.03
-1.70%